<?xml version="1.0" encoding="UTF-8"?>
<ref id="B83-molecules-25-04078">
 <label>83.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Langford</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Mares</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Novotna</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Vachova</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Novakova</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Notcutt</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Ratcliffe</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis</article-title>
  <source>J. Neurol.</source>
  <year>2013</year>
  <volume>260</volume>
  <fpage>984</fpage>
  <lpage>997</lpage>
  <pub-id pub-id-type="doi">10.1007/s00415-012-6739-4</pub-id>
  <?supplied-pmid 23180178?>
  <pub-id pub-id-type="pmid">23180178</pub-id>
 </element-citation>
</ref>
